首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neurology and therapy

缩写:

ISSN:2193-8253

e-ISSN:2193-6536

IF/分区:4.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引935
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Logan D Schneider,Chad M Ruoff,David T Plante et al. Logan D Schneider et al.
Introduction: A phase 4, prospective, open-label study of low-sodium oxybate (LXB) in narcolepsy (type 1 [NT1] or 2 [NT2]) or idiopathic hypersomnia included novel symptom outcomes important to patients (Jazz DUET; NCT058...
Babak Haji,Amir Abbas Tahami Monfared;Alzheimer’s Disease Neuroimaging Initiative Babak Haji
Introduction: Multimodal Alzheimer's disease (AD) cohorts capture cognition, function, neuroimaging, and fluid biomarkers, yet overall disease severity remains difficult to summarize on a single clinically meaningful scal...
Soania Mathur,Harold de Wit,Becky Jones et al. Soania Mathur et al.
Introduction: Parkinson's disease is a progressive neurodegenerative condition; there are no treatments currently available to slow disease progression, and no cure. Scientists are studying new treatments, such as disease...
Mohita Kumar,Alexandria Harrold,Minjee Park et al. Mohita Kumar et al.
Introduction: Rozanolixizumab is indicated for the treatment of adults with generalized myasthenia gravis (MG). This retrospective, non-interventional cohort study evaluated adults with MG initiating rozanolixizumab in th...
Kendra A K Lawrence,Lisa Belter,Mary Curry et al. Kendra A K Lawrence et al.
Introduction: There is a paucity of real-world evidence on the impact of early treatment as well as polytherapy use on advanced motor milestone achievement in children with spinal muscular atrophy (SMA) with ≤ 2 survival...
Norio Chihara,Justin Lee,Jeffrey C Yu et al. Norio Chihara et al.
Introduction: Eculizumab and ravulizumab [complement component 5 inhibitor therapies (C5ITs)] and satralizumab (interleukin-6 receptor inhibitor) are approved for treatment of anti-aquaporin-4 antibody-positive neuromyeli...
Xiaoqin Yang,Nicolae Done,Marianne Cunnington et al. Xiaoqin Yang et al.
Introduction: Neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN) is a chronic condition associated with significant morbidity. While patient outcomes have been characterized, the burden on caregivers of adult ...
Joanna Woźniak-Mitał,Paweł Rasmus,Marta Strombek-Milczarek et al. Joanna Woźniak-Mitał et al.
Introduction: Alzheimer's disease (AD) and mild cognitive impairment (MCI) are progressive neurodegenerative conditions with limited therapeutic options. Neuromodulation techniques such as transcranial direct current stim...
Herbert Peeples,Keshia Maughn,Christopher Dieyi et al. Herbert Peeples et al.
Introduction: This retrospective, longitudinal, observational study of claims data assessed provider access barriers among patients (aged ≥ 18 years) with epilepsy enrolled in Medicaid in the United States. ...
Anne W Alexandrov,Anne M Ryschon,Huimahn A Choi et al. Anne W Alexandrov et al.
Introduction: Post-stroke dysphagia is associated with increased healthcare costs and resource utilization. This analysis sought to evaluate acute clinical and economic outcomes among patients with stroke, with and witho...